the propaganda that became federal law
Before cannabis was illegal, it was in the U.S. Pharmacopeia — prescribed for pain, neurological disorders, and dozens of other conditions for 87 years. The decision to remove it wasn't driven by new science. A newspaper baron protecting a timber fortune drove it, and a federal commissioner turned that coverage into congressional testimony. This is what the documented record shows.
Where it started
Most people who know anything about cannabis prohibition have heard the DuPont angle — synthetic fibers, industrial hemp as a competitive threat to nylon. There's something to it. DuPont's financial interests were not neutral. But that's not where the stigma was manufactured. The stigma was built in a newsroom, and it was built deliberately.
William Randolph Hearst owned one of the largest newspaper chains in American history — 28 papers at peak reach, landing on millions of doorsteps every day. He also owned millions of acres of timber. Hemp paper threatened that investment directly. Hearst had both a motive and an unmatched megaphone. DuPont had lawyers. Hearst had the public.1
The playbook
"The passage of the Marihuana Tax Act was not based on sound science. It was primarily due to misinformation on the part of William Randolph Hearst and Harry Anslinger's campaign against African-American minorities and Mexican immigrant workers."
— Derek Rosenzweig · PA Legislative Testimony · 2019 · expert witness on prohibition history
Beginning around 1930, Hearst's papers ran a coordinated wave of stories connecting cannabis to violence, insanity, and moral collapse. The framing was almost always racial — stories featured Black or Mexican characters as perpetrators, connecting the plant to communities that white, middle-class readers were already primed to fear.2
The word "marijuana" itself was part of the strategy. Cannabis was clinical, familiar, American — it was in the Pharmacopeia, in medicine cabinets. It was not threatening. Marihuana sounded foreign and dangerous. The deliberate rebranding created linguistic distance between Americans and a plant they had been using medicinally for decades. That distance made fear possible.3
Propaganda to policy
| Year | What happened | Why it matters |
|---|---|---|
| 1850 | Cannabis added to the U.S. Pharmacopeia. Prescribed for neuralgia, convulsive disorders, pain, alcoholism, and over a dozen other conditions. | Used medically in America for 87 years before criminalization |
| 1930 | Harry Anslinger appointed first commissioner of the Federal Bureau of Narcotics. Hearst newspapers begin the coordinated "marihuana" campaign — sensationalized headlines, racial panic, manufactured crisis. | A media operation, not a public health response |
| 1936 | Reefer Madness released — church-funded, Hearst-amplified. Fictional panic reaches theaters nationwide. Public opinion fully primed. | The fictional becomes the official narrative |
| 1937 | Anslinger testifies before Congress, citing Hearst newspaper stories as scientific evidence. The Marihuana Tax Act passes in under two minutes of debate. | Yellow journalism laundered into federal law4 |
| 1942 | Cannabis removed from the U.S. Pharmacopeia. Zero new pharmacological evidence supported the removal. | 92 years of medical use erased without scientific justification5 |
| 1970 | Nixon's Controlled Substances Act places cannabis in Schedule I — alongside heroin, above cocaine and meth. His own Shafer Commission recommends against it. Nixon overrides them. | Political override of the government's own scientific body6 |
| Today | Schedule I classification remains. Federal research blockade intact. Only 9% of U.S. medical schools include cannabis in curriculum. | The infrastructure is still running |
The trap
Schedule I requires that a substance have "no accepted medical use." That classification is then used to deny research approval that would produce evidence of medical use. You cannot demand evidence while blocking the research. The circular logic is not an accident — it is a design feature of the system as it was built.
Anslinger laundered Hearst's yellow journalism into congressional testimony. Congress codified that testimony as law. Nixon then used that law as a political weapon — his own aide, John Ehrlichman, later confirmed on record that the War on Drugs was designed to disrupt Black communities and antiwar protesters. The plant was the pretext. The stigma was the weapon.7
The classification built on that 1937 foundation is still active law. It still blocks federally funded clinical trials. It's still why your doctor has almost certainly received zero clinical training on cannabinoid medicine. It's still why, when people arrive at a dispensary after the traditional healthcare system fails them, they meet a budtender instead of a clinician — and encounter high-THC products with no guidance instead of balanced, evidence-informed formulations.
The present cost
| Finding | Status | Source |
|---|---|---|
| Anslinger cited Hearst newspaper stories as scientific evidence in his 1937 congressional testimony | Documented | Congressional Record, 1937 |
| Nixon's Shafer Commission recommended against Schedule I; Nixon overrode them for political reasons | Political override | Shafer Commission Report, 1972 |
| Nixon aide confirmed on record that the War on Drugs targeted Black communities and antiwar protesters by design | On-record admission | Harper's Magazine, 2016 |
| Cannabis removed from U.S. Pharmacopeia with zero new pharmacological justification | Documented gap | U.S. Pharmacopeia, 1942 |
| 9% of U.S. medical schools include cannabis in curriculum; 84.9% of residents report zero clinical training | Active education gap | JAMA, 2017 |
| Federal Schedule I classification continues to block approval of clinical cannabis research | Active blockade | DEA scheduling rules, ongoing |
"Cannabis has no accepted medical use — that's why it's Schedule I."
Cannabis was prescribed in America for 87 years. Its removal from the Pharmacopeia was driven by a media campaign, not pharmacological evidence. Schedule I reflects a political decision made in 1937, not a scientific consensus reached at any point.
"We need more research before we can change policy."
The Schedule I classification blocks the federally funded research that would produce that evidence. Demanding research while blocking it is not a scientific position — it is a policy design that maintains the status quo by making reform evidence-impossible.
"Drug enforcement is about public safety, not race."
Anslinger's campaign was explicitly built on racial panic. Nixon's aide confirmed on record that the War on Drugs targeted Black communities by design. Enforcement patterns that persist today follow the documented origin of the policy.
Where we stand
The Schedule I classification is built on Anslinger's congressional testimony — which was built on Hearst's yellow journalism. The scientific foundation was fabricated. Policy built on fabrication should not survive peer review, let alone 87 years of enforcement.
You cannot demand evidence of medical value while classifying cannabis in a way that blocks the research to produce that evidence. The circular logic is a design feature of the current system, not an oversight. Dismantling it requires specific legislative action, not incremental scheduling review.
The Marihuana Tax Act of 1937 was driven by a coordinated media campaign, not science. Congress should formally acknowledge this documented history as the basis for comprehensive reform — not as a symbolic gesture, but as a prerequisite for credible policy change.
Nine percent is not a knowledge gap — it is a policy failure. Medical schools should be required to include endocannabinoid system pharmacology in standard training. Patients deserve clinicians who have been taught the science that exists, not kept ignorant of it.
Anslinger's campaign was explicitly built on racial panic. Disproportionate arrest and incarceration rates in Black and brown communities are not a coincidence — they follow the documented origin of the policy. Scheduling reform without enforcement reform is incomplete.